Remdesivir and COVID-19 - Authors' reply
| Errataetall: |
CommentOn: Lancet. 2020 Oct 3;396(10256):952. - PMID 33010830 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:396 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 396(2020), 10256 vom: 03. Okt., Seite 954 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Yeming [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
3QKI37EEHE |
|---|
| Anmerkungen: |
Date Completed 07.10.2020 Date Revised 07.12.2022 published: Print CommentOn: Lancet. 2020 Oct 3;396(10256):952. - PMID 33010830 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S0140-6736(20)32015-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31581134X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31581134X | ||
| 003 | DE-627 | ||
| 005 | 20231225155725.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(20)32015-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1052.xml |
| 035 | |a (DE-627)NLM31581134X | ||
| 035 | |a (NLM)33010835 | ||
| 035 | |a (PII)S0140-6736(20)32015-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Yeming |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Remdesivir and COVID-19 - Authors' reply |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.10.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Lancet. 2020 Oct 3;396(10256):952. - PMID 33010830 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Ribonucleotides |2 NLM | |
| 650 | 7 | |a remdesivir |2 NLM | |
| 650 | 7 | |a 3QKI37EEHE |2 NLM | |
| 650 | 7 | |a Adenosine Monophosphate |2 NLM | |
| 650 | 7 | |a 415SHH325A |2 NLM | |
| 650 | 7 | |a Alanine |2 NLM | |
| 650 | 7 | |a OF5P57N2ZX |2 NLM | |
| 700 | 1 | |a Gu, Xiaoying |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Jiuyang |e verfasserin |4 aut | |
| 700 | 1 | |a Cao, Bin |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Chen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 396(2020), 10256 vom: 03. Okt., Seite 954 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:396 |g year:2020 |g number:10256 |g day:03 |g month:10 |g pages:954 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(20)32015-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 396 |j 2020 |e 10256 |b 03 |c 10 |h 954 | ||